EFPIA
Sanofi chief executive to lead EFPIA
June 26, 2013Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty
Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …
ABPI supply chain warning
March 7, 2013Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA
The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …
UCB warns of data ‘voyeurism’
February 27, 2013Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy
UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …
£20m research boost for Scottish biotech
February 11, 2013Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA
BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …
New boost for drug candidates
December 5, 2012Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden
A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …
EMA’s five points on data release
November 27, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency
The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …
EFPIA rejects ‘indiscriminate’ transparency
November 16, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials
Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …
Europe looking to revamp clinical trial laws
July 25, 2012Research and Development, Sales and Marketing EFPIA, EU, Europe, clinical trials
The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …
Witty warns EU leaders over pricing
June 27, 2012Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing
Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …
Pharma calls for urgent change in German system
June 8, 2012Sales and Marketing AMNOG, EFPIA, Germany, Trajenta, VFA
Europe’s pharma industry has called on the German government to re-think its approach to pricing, saying it is could cause …
Public-private alliance to discover new antibiotics
May 25, 2012AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection
A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …
Industry supports bid to revitalise antibiotic research
November 17, 2011Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic
The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …
Price transparency and timing at risk, warns EFPIA
June 9, 2011Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing
Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …
Richard Bergström takes DG role at EFPIA
March 18, 2011Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing
European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …
Europe votes in new anti-counterfeit law
February 21, 2011Manufacturing and Production EFPIA, counterfeits, supply chain
The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
